893665755	893665755	CD	B-NP	O
|	|	NN	I-NP	O
OMH	OMH	NN	I-NP	O
|	|	NN	I-NP	O
16870436	16870436	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8201500	8201500	CD	B-NP	O
|	|	CC	I-NP	O
1/20/2006	1/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/10/2006	2/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2006	10/20/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DISQUE	DISQUE	NNP	B-NP	O
,	,	,	O	O
JOSEF	JOSEF	NNP	B-NP	B-protein
J	J	NNP	I-NP	O
595-33-92-6	595-33-92-6	CD	I-NP	O
Ty	Ty	NNP	I-NP	O
,	,	,	I-NP	O
Iowa	Iowa	NNP	I-NP	O
92159	92159	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
11/8/06	11/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GUNZALEZ	GUNZALEZ	NNP	B-NP	O
,	,	,	O	O
BUCK	BUCK	NNP	B-NP	O
RENATO	RENATO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Hospice	Hospice	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ATOVAQUONE	ATOVAQUONE	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	B-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
ADVAIR	ADVAIR	NNP	I-NP	I-protein
DISKUS	DISKUS	NNP	I-NP	I-protein
100/50	100/50	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
by	by	IN	B-PP	O
CHESLEY	CHESLEY	NN	B-NP	O
,	,	,	O	O
THEO	THEO	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
473186354	473186354	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/21/06	6/21/06	CD	B-NP	O
by	by	IN	B-PP	O
SLACUM	SLACUM	NNP	B-NP	O
,	,	,	O	O
MERLE	MERLE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
030336980	030336980	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
FOLIC	FOLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
15	15	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
GTEMC	GTEMC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
by	by	IN	B-PP	O
BOVEY	BOVEY	NNP	B-NP	O
,	,	,	O	O
DEVON	DEVON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ATIVAN	ATIVAN	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
REMERON	REMERON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
ELIXIR	ELIXIR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
SOLUTION	SOLUTION	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2-5	2-5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q2H	Q2H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Shortness	Shortness	NNP	B-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
ELIXIR	ELIXIR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
SOLUTION	SOLUTION	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
RAPAMUNE	RAPAMUNE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SIROLIMUS	SIROLIMUS	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
TORSEMIDE	TORSEMIDE	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
AMBIEN	AMBIEN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ZOLPIDEM	ZOLPIDEM	NN	I-NP	I-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Hutchison	Hutchison	NNP	I-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
,	,	,	O	O
PIOGLITAZONE	PIOGLITAZONE	NNP	B-NP	O
,	,	,	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SANDIMMUNE	SANDIMMUNE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
HEART	HEART	NNP	I-NP	O
TRANSPLANT	TRANSPLANT	NNP	I-NP	O
COUGH	COUGH	NN	I-NP	O
smoker	smoker	NN	I-NP	O
s/p	s/p	NN	I-NP	O
B	B	NN	I-NP	O
cataract	cataract	NN	I-NP	O
surg	surg	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PE	PE	NN	I-NP	O
1984	1984	CD	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
**	**	SYM	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
61yoM	61yoM	NN	B-NP	O
s/p	s/p	NN	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1985	1985	CD	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
EF	EF	NN	I-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
transplant	transplant	NN	B-NP	O
vasculapathy	vasculapathy	NN	I-NP	O
and	and	CC	O	O
accerlated	accerlate	VBN	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
rest	rest	NN	I-NP	O
lung	lung	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
essentially	essentially	RB	B-ADJP	O
end-stage	end-stage	JJ	I-ADJP	O
,	,	,	O	O
transferred	transfer	VBN	B-VP	O
here	here	RB	B-ADVP	O
from	from	IN	B-PP	O
MCH	MCH	NN	B-NP	B-protein
for	for	IN	B-PP	O
med	me	VBN	B-NP	O
mgmt	mgmt	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
several	several	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
returns	return	NNS	B-NP	O
shortly	shortly	RB	B-ADVP	O
w/same	w/same	VBP	B-VP	O
sx	sx	NN	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
transferred	transfer	VBN	B-VP	O
from	from	IN	B-PP	O
GHAMC	GHAMC	NN	B-NP	B-protein
with	with	IN	B-PP	O
vol	vol	NN	B-NP	O
overload	overload	NN	I-NP	O
on	on	IN	B-PP	O
Dobutamine	Dobutamine	NNP	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NNP	I-NP	O
for	for	IN	B-PP	O
med	med	JJ	B-NP	O
mgmt	mgmt	NN	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
1985	1985	CD	I-NP	O
,	,	,	O	O
transplant	transplant	NN	B-NP	O
vasculapathy	vasculapathy	NN	I-NP	O
and	and	CC	O	O
accelerated	accelerate	VBD	B-VP	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
ICMP	ICMP	NNP	B-NP	O
EF	EF	NNP	I-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
GIB	GIB	NN	B-NP	B-protein
,	,	,	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	O
**	**	SYM	B-VP	O
DAILY	DAILY	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
100/60	100/60	CD	I-NP	I-DNA
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
's	's	POS	B-NP	O
,	,	,	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
14cm	14cm	NN	I-NP	O
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	O
S1S2S3	S1S2S3	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
LEE	LEE	NN	I-NP	O
.	.	.	O	O

*************	*************	SYM	O	B-cell_type
HOSPITAL	HOSPITAL	NN	B-NP	I-cell_type
COURSE	COURSE	NN	I-NP	I-cell_type
*****************	*****************	SYM	O	I-cell_type
*	*	SYM	O	O
CVS	CVS	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
now	now	RB	B-ADVP	O
20yrs	20yr	VBZ	B-VP	O
post	post	JJ	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
with	with	IN	B-PP	O
many	many	JJ	B-NP	O
complications	complication	NNS	I-NP	O
including	include	VBG	B-PP	O
accelerated	accelerate	VBN	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
rest	rest	NN	B-NP	O
lung	lung	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
ICMP	ICMP	NN	B-NP	O
EF15	EF15	CD	B-NP	O
%	%	NN	I-NP	O
-	-	HYPH	B-ADVP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
end	end	VB	I-VP	O
stage	stage	NN	B-NP	O
with	with	IN	B-PP	O
room	room	NN	B-NP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VBP	I-VP	O
optimal	optimal	JJ	B-NP	O
medical	medical	JJ	I-NP	O
mgmt	mgmt	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
HOSPICE	HOSPICE	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
and	and	CC	O	O
IV	IV	CD	B-NP	O
Diuril	Diuril	NNP	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
inotropic	inotropic	JJ	B-NP	O
support	support	NN	I-NP	O
with	with	IN	B-PP	O
Dobutamine	Dobutamine	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
Torsemide	Torsemide	NN	I-NP	O
and	and	CC	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
once	once	RB	B-ADVP	O
he	he	PRP	B-NP	O
achieved	achieve	VBD	B-VP	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
Morphine	Morphine	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
so	so	RB	B-ADVP	O
.	.	.	O	O

Arrangements	Arrangement	NNS	B-NP	O
for	for	IN	B-PP	O
HOME	HOME	NN	B-NP	O
HOSPICE	HOSPICE	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
understands	understand	VBZ	B-VP	O
his	his	PRP$	B-NP	O
prognosis	prognosis	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
poor	poor	JJ	I-ADJP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
interventions	intervention	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	B-DNA
underlying	underlie	VBG	I-NP	O
heart	heart	NN	I-NP	O
diseas	disea	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
opitmized	opitmize	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
torsemide/HCTZ	torsemide/HCTZ	NN	I-NP	O
and	and	CC	I-NP	O
prn	prn	NN	I-NP	O
Morphine	Morphine	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
Levoflox	Levoflox	NNP	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
*	*	SYM	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
NPH	NPH	NN	B-NP	O
and	and	CC	I-NP	O
SS	SS	NN	I-NP	O
*********	*********	SYM	B-NP	O
DNR/DNI	DNR/DNI	NN	I-NP	O
***********	***********	SYM	B-NP	O
ADDITIONAL	ADDITIONAL	NN	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
new	new	JJ	I-NP	O
medictions	mediction	NNS	I-NP	O
include	include	VBP	B-VP	O
Torsemide	Torsemide	NN	B-NP	O
and	and	CC	I-NP	O
Hydrocholorthiazide	Hydrocholorthiazide	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
take	take	VB	I-VP	O
Levofloxacin	Levofloxacin	NNP	B-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
Coreg	Coreg	NNP	B-NP	O
any	any	DT	B-ADVP	O
longer	longer	RBR	I-ADVP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
use	use	VBP	B-VP	O
Morphine	Morphine	NNP	B-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NNP	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DEIS	DEIS	NNP	B-NP	O
,	,	,	O	O
ELIJAH	ELIJAH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NS99	NS99	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/24/06	8/24/06	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

